Fidelity Investments’s BioVie BIVI Stock Holding History

Fidelity Investments’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,294	Closed	-$20.9K	–	5436
2025 Q4	$18.9K	Buy	+16,294	New	+$26.2K	﹤0.01%	4482
2024 Q3	–	Sell	-29	Closed	-$1.18K	–	5504
2024 Q2	$1.18K	Sell	29 -33	-53%	-$1.58K	﹤0.01%	4785
2024 Q1	$3.27K	Buy	62 +60	+3,000%	+$6.15K	﹤0.01%	4607
2023 Q4	$218	Sell	2 -2	-50%	-$601	﹤0.01%	4878
2023 Q3	$1.27K	Buy	4 +3	+300%	+$1.17K	﹤0.01%	4616
2023 Q2	$340	Buy	+1	New	+$674	﹤0.01%	4856

Other funds holding BIVI

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Fidelity Investments's BIVI Position: Q1 2026 in Review

Fidelity Investments sold out of BioVie (BIVI) in Q1 2026, closing a stake of 16,294 shares — an estimated $20.9K sold.

Fidelity Investments first reported a position in BIVI in Q2 2023 and held it in 6 quarters. The position peaked at $18.9K in Q4 2025. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

Fidelity Investments reported no remaining BioVie position as of Q1 2026 after selling out during the quarter.
Fidelity Investments sold 16,294 BioVie shares in Q1 2026, an estimated $20.9K.
Fidelity Investments first reported a position in BioVie in Q2 2023 and held it in 6 quarters.
Fidelity Investments's BioVie position peaked at $18.9K in Q4 2025.
33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.